1Johnson GL, Lapadat R. Mitogen-aetivated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases [ J]. Science, 2002,298(11):1911.
2Kumar S,Beohm J,Lee JC. p38 MAP kinases:key signaling molecules as therapeutic targets for inflammatory diseases[J]. Nat Bey Drug Discov,2003,2(2) :717.
3Beeh KM, Kornmann O, Buhl R, et al. Neutrophil chemotaetic activity of suptum from patients with COPD : role of interleukin 8 and leukotriene B4[J].Chest,2003,123(10):1240.
4Rossi D, Zlotnik A. The biology of chemokines and their receptors [J].Ann Rev Immunol,2000,18(2) :217.
5Saetta M, Mariani M, Panina-Bordignon P, et al. Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med,2003,165(5) : 1404.
6Vernooy JH, Kucukaycan M, Jacobs JA, et al. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum [J].Am J Respir Crit Care Med,2002, 166(5) : 1218.
7Markham A, Lamb HM. Infliximab: a review of its use in the management of rheumatoid arthritis[J]. Drugs,2000,59(7):1341.
8Montushi P, Kharitonov SA, Ciabattoni G, et al. Exhaled leukotrienes and prostaglandins in COPD[J]. Thorax,2003,58(4) :585.
9Gompertz S, Stockley RA. A randomized, placebo-controlled trial of a leukotriene synthesis inhibitor in patients with COPD [J]. Chest, 2002,122(2) :289.
10Dallas SL, BosserJL, Mundy GB, et al. Proteolysis of latent transforming growth factor-β(TGF-β)-binding protein-1 by osteoxlasts: a cellular mechanism for resease of TGF-β from bone matrix[J]. J Biol Chem,2002,277:21352.
